InterDigital has secured a new multi-year patent license agreement with LG Electronics, extending its royalty base into consumer electronics like digital TVs and display monitors, signaling a strategic diversification of its licensing revenue.
As Palantir Technologies reports a massive surge in U.S. government revenue, CEO Alex Karp publicly defends the company's controversial surveillance platforms, insisting they contain safeguards against overreach. The defense comes amidst growing public and political scrutiny over its contracts with immigration enforcement agencies.
Palantir Technologies' stock surged after hours as its Q4 earnings and bullish 2026 guidance surpassed analyst forecasts, signaling a powerful acceleration in its AI software business and vindicating CEO Alex Karp's long-term strategy.
NXP Semiconductors projects first-quarter revenue above analyst expectations, fueled by resilient automotive chip sales and signs of stabilization in the industrial sector, despite ongoing softness in communications infrastructure.
The data analytics firm's fourth-quarter results showcase a decisive shift, with U.S. commercial revenue soaring 137% and profitability silencing long-time skeptics, even as its premium valuation demands sustained execution.
As Amazon prepares to release its Q4 earnings, analysts are eyeing accelerated AWS growth and robust advertising revenue as key drivers that could propel the stock higher, mirroring its October surge.
Opera Limited's stock soared nearly 17% following its announcement of deeper integration of Tether's USDT and gold-backed tokens into its MiniPay wallet, targeting underbanked regions. The rally was further bolstered by stronger-than-expected preliminary Q4 2025 revenue figures.
Despite a star-studded client list and explosive revenue growth, IonQ's towering valuation and the nascent state of quantum computing signal significant risk for investors eyeing the recent sell-off.
The data analytics firm smashed fourth-quarter estimates, fueled by a near-doubling of its U.S. revenue. While bullish forecasts signal confidence in its AI-driven future, analysts point to persistent challenges in government contracting and investor relations.
Disney's stock fell sharply Monday, reflecting investor unease over the financial toll of its transition from traditional cable to direct-to-consumer streaming, despite overall revenue growth.
While many AI stocks trade at sky-high premiums, Nebius Group presents a contrasting case. Analysts project a staggering revenue surge for 2026, suggesting its current valuation might not fully reflect its growth trajectory in the competitive cloud AI space.
Walt Disney Co. shares fell sharply Thursday following its Q1 2026 earnings report, as investor focus shifted from beating profit expectations to uncertainty surrounding CEO Bob Iger's successor and cautious guidance on park attendance.
The data analytics firm smashed Wall Street forecasts for the fourth quarter, reporting a 70% revenue surge to $1.4 billion, driven by explosive growth in its U.S. operations. Its bullish outlook for 2025 further signals resilience amid sector-wide anxieties.
While Medtronic's shares have trailed the S&P 500 over the past year, Wall Street maintains a cautiously optimistic stance, buoyed by strong recent earnings and raised guidance.
Despite posting record membership, revenue, and a landmark $1 billion quarter, SoFi Technologies' stock faces a steep pullback. While Wall Street maintains a cautious 'Hold,' the company's strategic pivot and robust forecasts suggest the current dip may present a compelling entry point for growth investors.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
NXP Semiconductors (NXPI) reports Q4 2025 earnings after the bell today. With Wall Street eyeing modest growth, the chipmaker's performance in its core automotive segment—nearly 60% of revenue—will be the key test for its 2026 trajectory.
New research reveals a stark disconnect: while a majority of firms are ramping up investment in incentive pay to fuel growth, widespread execution errors are rendering these costly programs ineffective, leaving potential revenue on the table.
Tenet Healthcare has regained complete ownership of its revenue cycle management subsidiary Conifer, buying out CommonSpirit Health's minority stake in a deal valued at nearly $2.7 billion. The move signals Tenet's renewed commitment to the business and plans for significant AI investment.
